22 May 2013
Keywords: unimed, ntz, gets, priority, review, pharmaceuticals, been
Article | 09 March 1998
Unimed Pharmaceuticals has been granted a priority review by the US Foodand Drug Administration for NTZ (nitazoxanide) for the treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 March 1998
5 March 1998
© 2013 thepharmaletter.com